Showing results (61-70 of 133) with videos related to

Sort By:
Pageof 14
Oncotarget|April 13, 2018
Pomalidomide enhanced gemcitabine and nab-paclitaxel on pancreatic cancer both in vitro and in vivoNobuhiro Saito, Yoshihiro Shirai, Tadashi Uwagawa, et al.
Human Gene Therapy|March 13, 2015
Hematopoietic Stem Cell Gene Therapy Corrects Neuropathic Phenotype in Murine Model of Mucopolysaccharidosis Type IITaichi Wakabayashi, Yohta Shimada, Kazumasa Akiyama, et al.
Annals of Gastroenterological Surgery|June 5, 2018
Glycogen synthase kinase-3β activity plays a key role in the antitumor effect of nafamostat mesilate in pancreatic cancer cellsKoichiro Haruki, Hiroaki Shiba, Yohta Shimada, et al.
Molecular Genetics and Metabolism|October 11, 2011
Endoplasmic reticulum stress induces autophagy through activation of p38 MAPK in fibroblasts from Pompe disease patients carrying c.546G>T mutationYohta Shimada, Hiroshi Kobayashi, Shiho Kawagoe, et al.
The Journal of Surgical Research|July 9, 2013
Combination chemotherapy of nafamostat mesylate with gemcitabine for gallbladder cancer targeting nuclear factor-κB activationRyota Iwase, Koichiro Haruki, Yuki Fujiwara, et al.
Surgery|July 30, 2019
Prevention of early liver metastasis after pancreatectomy by perioperative administration of a nuclear factor-κB inhibitor in miceNobuhiro Saito, Tadashi Uwagawa, Ryouga Hamura, et al.
Surgery|January 18, 2017
Recombinant thrombomodulin suppresses tumor growth of pancreatic cancer by blocking thrombin-induced PAR1 and NF-κB activationYoshihiro Shirai, Tadashi Uwagawa, Hiroaki Shiba, et al.
Digestive Diseases and Sciences|July 19, 2012
Inhibition of nuclear factor-κB enhances the antitumor effect of paclitaxel against gastric cancer with peritoneal dissemination in miceKoichiro Haruki, Hiroaki Shiba, Yuki Fujiwara, et al.
Surgery Today|August 16, 2012
Nuclear factor κB activity correlates with the progression and prognosis of pancreatic cancer in a mouse modelKenei Furukawa, Tadashi Uwagawa, Koichiro Haruki, et al.
Cancer Letters|November 8, 2015
Dual inhibition of nuclear factor kappa-B and Mdm2 enhance the antitumor effect of radiation therapy for pancreatic cancerYoshihiro Shirai, Hiroaki Shiba, Ryota Iwase, et al.
Pageof 14